Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide effervescent tablets vs viscous budesonide vs placebo in eosinophilic esophagitis
2009-016692-29Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of budesonide in eosinophilic esophagitis (EoE) (4 arms), sponsored by Dr. Falk Pharma GmbH. Started Nov 2011; status: completed.
02
Drugs
budesonide
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2009-016692-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016692-29.